Enhanced hydrogel xenograft for open maxillary sinus augmentation
Official title: Clinical, Radiographic and Histologic Assessment of a New Xenograft Enhanced With Hydrogel in Augmentation of the Maxillary Sinus: A Randomized Controlled Trial
Run by Misr International University · NCT07737704 · Data updated 2026-11-12
This study tests a hydrogel-enhanced xenograft material to lift the sinus floor during open augmentation and sees if it improves bone formation and tissue response compared with doing the augmentation without graft material.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Misr International University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 3 sites (Ismailia, Ismailia Governorate and 2 other locations) |
| Status | Recruiting |
| Started | August 10, 2026 |
| Main results expected | June 10, 2027 |
| Study ends | December 12, 2027 |
| Registry record updated | July 30, 2026 |
| Trial ID | NCT07737704 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with at least one missing tooth in the atrophic posterior maxilla and an alveolar height of less than 5 mm requiring open sinus elevation.
✕Probably not a fit
Patients with uncontrolled medical conditions, active sinus infection, heavy smoking, or contraindications to implant-supported restorations may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, interventional study compares a hydrogel-enhanced xenograft to a graftless approach for lateral maxillary sinus floor elevation in adults with severe posterior maxillary atrophy. Participants undergo sinus elevation with either the xenograft or a graftless method, followed by monitoring of swelling and pain and radiographic evaluation of newly formed bone before implant placement. Outcomes include soft tissue reaction, quantity and quality of formed bone, and radiographic changes over a staged augmentation process. The null hypothesis is that there is no difference between the two methods in tissue response and bone formation. Thirty sites will be studied at two Suez Canal University locations under Misr International University sponsorship.
Why it matters
Potential benefit: If successful, the hydrogel-enhanced xenograft could provide better bone formation and softer tissue response, potentially improving implant success in atrophic posterior maxilla.
How similar studies have gone: Previous approaches to maxillary sinus augmentation have explored graft materials and graftless methods; this study presents a novel hydrogel-enhanced xenograft approach whose comparative performance remains to be established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult male/female patients above the age of 18. * Patients with one or more teeth requiring implant supported dental restoration in atrophic posterior maxilla. * Alveolar bone height less than 5 mm at the defective site. * Good oral hygiene. * Patient's consensual agreement to be enrolled in the study. Exclusion Criteria: * Medically compromised patients with conditions contraindicating surgery (eg. uncontrolled diabetics, bisphosphonate intake, radio or chemotherapy). * Patients with active infection at or related to the site of surgery (eg. acute sinusitis). * Heavy smokers. * Patients not indicated for an implant supported restoration at the time of enrollement. (Patients developing any medical condition that interferes with the outcomes after enrolment in the study will be excluded).
Where it's running
-
Suez Canal University
Ismailia, Ismailia Governorate, Egypt Recruiting -
Suez Canal University
Ismailia, Egypt Recruiting -
Suez Canal University
Ismailia, Egypt Recruiting
Study contacts
- Study coordinator: Ramy H El Shater, MDS
- Email: ramy.hamdy@miuegypt.edu.eg
- Phone: +201014111431
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neocement® Inject P for dental bone augmentation and regeneration.
This study will try Neocement® Inject P, an injectable calcium‑phosphate bone substitute, in adults having reconstructive dental or maxillofacial surgery to see if it is safe and helps bone heal.
-
Neobone® safety and performance in dental bone grafting
This project will collect real-world data to see if Neobone® is safe and helps bone heal in adults having reconstructive dental procedures.
-
Bone grafting at implant removal to help success of putting a new implant in the same spot
This study tests whether doing bone grafting at the same time as removing a failed dental implant helps people who plan to get a new implant in the same location.
-
Tenting the Schneiderian membrane of the maxillary sinus using titanium mesh
This trial will test whether using titanium mesh to lift and tent the sinus membrane improves outcomes for patients needing maxillary sinus floor augmentation for dental implants.
-
Predictors of complications after transosseous Versah maxillary sinus lift
This project will test whether factors like residual bone height, sinus membrane thickness, and sinus anatomy predict complications after a transosseous (Versah) sinus lift for people needing implants in the back upper jaw.
-
Rebuilding upper jaw ridge using retromolar bone blocks with or without a collagen membrane
This will test whether putting a collagen membrane over an onlay bone block and particulate bone in the upper jaw helps people who need ridge rebuilding get more bone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.